For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250507:nRSG7200Ha&default-theme=true
RNS Number : 7200H Argentex Group PLC 07 May 2025
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Argentex Group PLC
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Argentex Group PLC
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? OFFEREE
(e) Date position held: 6 May 2025
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary shares of £0.0001 each
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: NIL 0.00 NIL 0.00
(2) Cash-settled derivatives: NIL 0.00 NIL 0.00
(3) Stock-settled derivatives (including options) and agreements to NIL 0.00 NIL 0.00
purchase/sell:
NIL 0.00 NIL 0.00
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
(A) The directors of the Offeree (and their close relatives and the related
trusts of any of them) have interests in Ordinary Shares in the Offeree as
follows:
Name No. Ordinary Shares held % of issued ordinary share capital
Nigel Railton 1,704,137* 1.41
Tim Rudman 8,766 0.00
Jonathan Gray 100,000 0.08
Tim Haldenby 54,716 0.04
*Inclusive of 274,615 Ordinary Shares held beneficially by his wife, Elizabeth
Railton.
(B) The following director of the Offeree has an award granted under the
Argentex 2025 Senior Executive Long Term Incentive Plan (the "Argentex 2025
LTIP") as follows:
Name Type of award No. growth A shares of £0.0001 each in the capital of Argentex Capital Grant date Grant price Vesting date
Limited* held
Tim Rudman Growth shares** 1,040 3 April 2025 £55.38 per share The end of a specified period following publication of the audited results of
the Offeree for the financial year ending 31 December 2028.
*A wholly owned subsidiary of the Offeree.
**The growth shares are exchangeable for Ordinary Shares on the basis set out
in the articles of association of Argentex Capital Limited subject to the
Ordinary Shares having a value in excess of 65 pence per Ordinary Share on the
vesting date or, if earlier, on the date of a change of control of the
Offeree. Should the proposed acquisition of the Offeree by IFX (UK) Ltd
(trading as IFX Payments) complete, this performance condition will remain
unsatisfied and the growth shares will be acquired by the Offeree for nil
consideration and (at the Offeree's option) will convert into deferred shares
in the capital of Argentex Capital Limited (on a 1:1 basis).
*Inclusive of 274,615 Ordinary Shares held beneficially by his wife, Elizabeth
Railton.
(B) The following director of the Offeree has an award granted under the
Argentex 2025 Senior Executive Long Term Incentive Plan (the "Argentex 2025
LTIP") as follows:
Name Type of award No. growth A shares of £0.0001 each in the capital of Argentex Capital Grant date Grant price Vesting date
Limited* held
Tim Rudman Growth shares** 1,040 3 April 2025 £55.38 per share The end of a specified period following publication of the audited results of
the Offeree for the financial year ending 31 December 2028.
*A wholly owned subsidiary of the Offeree.
**The growth shares are exchangeable for Ordinary Shares on the basis set out
in the articles of association of Argentex Capital Limited subject to the
Ordinary Shares having a value in excess of 65 pence per Ordinary Share on the
vesting date or, if earlier, on the date of a change of control of the
Offeree. Should the proposed acquisition of the Offeree by IFX (UK) Ltd
(trading as IFX Payments) complete, this performance condition will remain
unsatisfied and the growth shares will be acquired by the Offeree for nil
consideration and (at the Offeree's option) will convert into deferred shares
in the capital of Argentex Capital Limited (on a 1:1 basis).
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None.
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None.
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 7 May 2025
Contact name: Alethia McDonald
Telephone number: +44 (0) 20 3862 1604
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEEUBUARVBUVRAR